- Home
- LRMR vs MHN Comparison
LRMR vs MHN Comparison
Compare LRMR & MHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- MHN
- Stock Information
- Founded
- LRMR N/A
- MHN 1997
- Country
- LRMR United States
- MHN United States
- Employees
- LRMR N/A
- MHN N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- MHN Investment Bankers/Brokers/Service
- Sector
- LRMR Health Care
- MHN Finance
- Exchange
- LRMR Nasdaq
- MHN Nasdaq
- Market Cap
- LRMR 332.1M
- MHN 293.6M
- IPO Year
- LRMR N/A
- MHN N/A
- Fundamental
- Price
- LRMR $3.45
- MHN $10.29
- Analyst Decision
- LRMR Strong Buy
- MHN
- Analyst Count
- LRMR 7
- MHN 0
- Target Price
- LRMR $16.71
- MHN N/A
- AVG Volume (30 Days)
- LRMR 1.8M
- MHN 59.2K
- Earning Date
- LRMR 11-05-2025
- MHN 01-01-0001
- Dividend Yield
- LRMR N/A
- MHN 4.17%
- EPS Growth
- LRMR N/A
- MHN N/A
- EPS
- LRMR N/A
- MHN N/A
- Revenue
- LRMR N/A
- MHN N/A
- Revenue This Year
- LRMR N/A
- MHN N/A
- Revenue Next Year
- LRMR N/A
- MHN N/A
- P/E Ratio
- LRMR N/A
- MHN N/A
- Revenue Growth
- LRMR N/A
- MHN N/A
- 52 Week Low
- LRMR $1.61
- MHN $8.69
- 52 Week High
- LRMR $9.50
- MHN $10.81
- Technical
- Relative Strength Index (RSI)
- LRMR 39.35
- MHN 47.02
- Support Level
- LRMR $3.16
- MHN $10.29
- Resistance Level
- LRMR $4.50
- MHN $10.36
- Average True Range (ATR)
- LRMR 0.30
- MHN 0.07
- MACD
- LRMR -0.10
- MHN -0.04
- Stochastic Oscillator
- LRMR 24.09
- MHN 15.38
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About MHN Blackrock MuniHoldings New York Quality Fund Inc.
BLACKROCK MUNIHOLDINGS NEW YORK QUALITY FUND, INC. is a closed-ended management investment company. The fund's investment objective is to provide shareholders with current income exempt from federal income tax and New York State and New York City personal income taxes.